135 related articles for article (PubMed ID: 38178755)
21. [Highlights of 2009 Kunming symposium on nasopharyngeal carcinoma].
Gan KJ; Xia YF
Ai Zheng; 2009 Oct; 28(10):1009-11. PubMed ID: 19799805
[No Abstract] [Full Text] [Related]
22. Epstein-Barr virus induces viral nuclear antigen in nasopharyngeal epithelial cells.
Desgranges C; de-Thé G
Lancet; 1977 Dec; 2(8051):1286-7. PubMed ID: 73981
[No Abstract] [Full Text] [Related]
23. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
24. Nasopharynx cancer: Induction or adjuvant? That is the question.
Lee NY; Sherman EJ
Cancer; 2020 Aug; 126(16):3620-3623. PubMed ID: 32497264
[No Abstract] [Full Text] [Related]
25. Epstein-Barr virus-associated poorly differentiated nasopharyngeal adenocarcinoma: a case report and literature review.
Zhang S; Huang XP; Li HH; Chen ZT
J Int Med Res; 2023 May; 51(5):3000605231173839. PubMed ID: 37203382
[TBL] [Abstract][Full Text] [Related]
26. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient.
Nie Y; Sun Y; Wang Y; Liu C; Zhao C; Luo B
Arch Virol; 2013 May; 158(5):1031-7. PubMed ID: 23266831
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
Xue F; He X
Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
Rac J; Haas F; Schumacher A; Middeldorp JM; Delecluse HJ; Speck RF; Bernasconi M; Nadal D
PLoS One; 2015; 10(4):e0123645. PubMed ID: 25856387
[TBL] [Abstract][Full Text] [Related]
30. Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Xue N; Xing S; Ma W; Sheng J; Huang Z; Xu Q
Technol Cancer Res Treat; 2020; 19():1533033820935773. PubMed ID: 32578505
[TBL] [Abstract][Full Text] [Related]
31. Metachronous occurrence of Epstein-Barr virus-associated primary ovarian Burkitt lymphoma and second primary nasopharyngeal carcinoma.
Chou CT; Chang KC; Hsiao JR; Su YC; Ou CY
Pathol Int; 2022 Apr; 72(4):261-263. PubMed ID: 35128744
[No Abstract] [Full Text] [Related]
32. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.
Huang DP; Ho JH; Henle W; Henle G
Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471
[No Abstract] [Full Text] [Related]
33. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma.
Chen CL; Hsu MM
Hum Pathol; 2000 Feb; 31(2):227-32. PubMed ID: 10685638
[TBL] [Abstract][Full Text] [Related]
34. Expression of an Epstein-Barr-virus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells.
Shao X; He Z; Chen Z; Yao K
Int J Cancer; 1997 May; 71(5):750-5. PubMed ID: 9180141
[TBL] [Abstract][Full Text] [Related]
35. Frequency of Epstein-Barr virus and human papilloma virus in patients with nasopharyngeal carcinoma.
Altekin I; Taş A; Yalcin O; Guven SG; Aslan Z; Adali MK; Karasalihoğlu AR
Eur Arch Otorhinolaryngol; 2020 Jul; 277(7):2041-2047. PubMed ID: 32170419
[TBL] [Abstract][Full Text] [Related]
36. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy.
Sham JS; Wei WI; Zong YS; Choy D; Guo YQ; Luo Y; Lin ZX; Ng MH
Lancet; 1990 Feb; 335(8686):371-4. PubMed ID: 1968116
[TBL] [Abstract][Full Text] [Related]
37. Synchronous occurrence of nasopharyngeal carcinoma and Hodgkin lymphoma.
Stokken J; Manz RM; Flagg A; Kate Gowans L; Anne S
Int J Pediatr Otorhinolaryngol; 2014 Jan; 78(1):154-6. PubMed ID: 24290306
[TBL] [Abstract][Full Text] [Related]
38. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
[TBL] [Abstract][Full Text] [Related]
40. The biology of EBV infection in human epithelial cells.
Tsao SW; Tsang CM; Pang PS; Zhang G; Chen H; Lo KW
Semin Cancer Biol; 2012 Apr; 22(2):137-43. PubMed ID: 22497025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
